Finance Watch: 2021 Is Now Two Away From 100 Biopharma IPOs
Three Health Care-Focused SPACs Also Went Public
Public Company Edition: Entrada’s initial public offering grossed $181.5m while Aura raised $75.6m and Biofrontera brought in $18m. Also, AnaptysBio received $250m in Jemperli royalty deal and 4D Molecular Therapeutics grossed $118.8m in a follow-on offering.
